|
| |
| | | 53904 | | 19.12.1996 | | Janssen-Cilag AG | | 12.04.2006 | | | | | | | | | | | 01.01.30. | | | | 01.01.30. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 05 | Durogesic Matrix 25 ug/h | Transdermales Pflaster | | N02AB03 | CI | | 06 | Durogesic Matrix 50 ug/h | Transdermales Pflaster | | N02AB03 | CI | | 07 | Durogesic Matrix 75 ug/h | Transdermales Pflaster | | N02AB03 | CI | | 08 | Durogesic Matrix 100 ug/h | Transdermales Pflaster | | N02AB03 | CI | | 09 | Durogesic Matrix 12 ug/h | Transdermales Pflaster | | N02AB03 | CI |
|
|
|
